logo
Kyle D. Edgington, Ph.D. Named Chief Development Officer for Cook Children's

Kyle D. Edgington, Ph.D. Named Chief Development Officer for Cook Children's

Experienced Fundraiser to Lead Campaign for $1.25 Billion Expansion
FORT WORTH, Texas, April 23, 2025 /PRNewswire/ — Cook Children's Health Care System is pleased to announce Kyle D. Edgington, Ph.D. is stepping into the role of Senior Vice President and Chief Development Officer for the Cook Children's Health Foundation.
After an extensive search, Cook Children's chose Dr. Edgington based on his experience and success in leadership, endowment growth, donor engagement and strategic partnerships. He began at Cook Children's on April 21, taking the fundraising helm for an ambitious $1.25 billion expansion project at Cook Children's Medical Center – Fort Worth.
'As we embark on the largest fundraising campaign in the history of Cook Children's, Kyle brings an expertise that makes him an ideal fit for our organization,' said Rick W. Merrill, president and CEO of Cook Children's Health Care System.
'His skillset and proven leadership will be key to raising philanthropic support required to expand and enhance our flagship medical center,' Mr. Merrill said. 'We look forward to Kyle's vital impact steering the fundraising effort for this transformative project.'
Dr. Edgington, a Fort Worth native, comes to Cook Children's after 16 years at The University of Texas at Dallas, where he held multiple teaching and administrative leadership roles. Most recently, as Vice President for Development and Alumni Relations for the university, he oversaw a 110-member team and a $15 million budget. Just a few of his achievements include:
Spearheading 'New Dimensions: The Campaign for UT Dallas,' which to date has raised $440 million toward a $750 million goal ; More than doubling the university's endowment, now valued at $868 million; and Boosting annual gift count by 183% and donor count by 70%.
Dr. Edgington holds a Ph.D. in Public Affairs from The University of Texas at Dallas, an MBA from Wayland Baptist University, and a bachelor's degree from Texas Tech University. In addition to his professional success, he has a long history of serving children in North Texas as a volunteer. He is a past president for Big Brothers Big Sisters Lone Star Foundation, as well as a head youth basketball coach for Allen Sports Association.
'Philanthropy is one of the oldest and most cherished traditions in health care, and few places embody its spirit more profoundly than Cook Children's. I am excited to join the organization during such a pivotal season of growth and look forward to the impact our work together will have in the community and beyond,' Edgington said.
In November 2024, Cook Children's unveiled a 10-year master plan, including the new West Tower, to help meet pediatric health care needs for the growing population of North Texas. The West Tower is a 760,000-square-foot expansion on the campus of our flagship medical center in Fort Worth. This project will increase capacity for critical care, cardiology and transitional care. This expansion also creates next level operating rooms with technology and equipment to support advanced programs like orthospine, neurosurgery, cardiothoracic surgery, robotics and more. This tower will be home to leading edge pediatric care, research and innovation demonstrating our commitment to building a healthier future for families in our community and for generations to come.
Sources of financing to build the West Tower will include a mix of operations, bonds and philanthropic support.
'We pledge at Cook Children's to do everything we can for the health and well-being of the children in our community,' Mr. Merrill said. 'Making our Fort Worth medical center bigger and better helps us fulfill that Promise. We're looking to the future and taking steps to deliver the state-of-the-art facilities that will allow us to continue providing exceptional care for children in our region and beyond.'
About Cook Children'sCook Children's is more than a health care system: we strive to be an extension of your family, growing with your child from their first steps to adulthood. By collaborating to deliver on our Promise—to improve the well-being of every child in our care and our communities, we connect the dots for our patients. Between primary and specialty. Between home and medical home. Between short-term care and long-term health.
Based in Fort Worth, Texas, we're 10,000+ dedicated team members strong, passionately caring for over 2 million patient encounters each year. Our integrated, not-for-profit organization spans two medical centers (including our state-of-the-art location in Prosper), two surgery centers, a physician network, home health services and a health plan. It also includes Child Study Center at Cook Children's, Cook Children's Health Services Inc., and Cook Children's Health Foundation. In 2024, Forbes named Cook Children's the top health care employer in the U.S., and third on the list of 'America's Best Large Employers.'
And our impact extends beyond the borders of Texas. We proudly treat children from virtually every state in the nation and 32 countries. By seeing the world through the eyes of children and their families from all backgrounds, we're able to shape health care suited to them: connected by kindness, imagination and respect—with an extra dose of magical wonder.
Discover more at www.cookchildrens.org.
Cook Children's Health Foundation StatusThe W.I. Cook Foundation, Inc. (dba Cook Children's Health Foundation) is a Non-Profit Hospital authorized under Section 501(C) 3 of the IRS code.
W.I. Cook Foundation, Inc. is the parent company of Cook Children's Health Care System which consists of nine companies.
CC Health Foundation and DonorsGenerosity expresses itself in many ways at Cook Children's, a not-for-profit organization. From life-saving research, the latest technology, or a furry friend on a hard day for our young patients, we can say with certainty that generosity heals. Donations to Cook Children's Health Foundation create the healing and moments of magic that make Cook Children's so special.
Matching the needs of the health care system with generous philanthropic support from the community allows Cook Children's to enhance patient programs and services. Each donation is a significant investment in the health and well-being of the children in our care and our communities.
When a child is sick or injured, families know they can turn to Cook Children's for help. From sniffles to surgery and everything in between, generosity connects the dots between our patients and the care they need.
Media ContactMedia@cookchildrens.org682-774-2810
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Dollar Tree (DLTR) Rose Following the Divestiture
Dollar Tree (DLTR) Rose Following the Divestiture

Yahoo

time10 minutes ago

  • Yahoo

Dollar Tree (DLTR) Rose Following the Divestiture

The London Company, an investment management company, released 'The London Company Mid Cap Strategy' second quarter 2025 investor letter. A copy of the letter can be downloaded here. US equities saw a double-digit surge in the second quarter following a sharp decline in the first quarter. The mid-cap composite rose 5.7% (5.5% net) in the second quarter, falling short of the Russell Midcap Index's 8.5% increase. Please review the fund's top 5 holdings to gain insight into their key selections for 2025. In its second quarter 2025 investor letter, The London Company Mid Cap Strategy highlighted stocks such as Dollar Tree, Inc. (NASDAQ:DLTR). Dollar Tree, Inc. (NASDAQ:DLTR) is a discount retailer. The one-month return of Dollar Tree, Inc. (NASDAQ:DLTR) was 11.63%, and its shares gained 10.21% of their value over the last 52 weeks. On July 29, 2025, Dollar Tree, Inc. (NASDAQ:DLTR) closed at $114.99 per share, with a market capitalization of $23.998 billion. The London Company Mid Cap Strategy stated the following regarding Dollar Tree, Inc. (NASDAQ:DLTR) in its second quarter 2025 investor letter: "Dollar Tree, Inc. (NASDAQ:DLTR) – DLTR was a top performer after it reached an agreement in March to sell its underperforming Family Dollar business, a decade-long drag on growth and margins. This divestiture has driven a stock re-rating, reflecting a higher-quality company focused on value creation at the Dollar Tree banner. The recent elimination of the de minimis exemption has yielded positive sentiment towards retailers like DLTR. We remain attracted to its pricing flexibility and margin enhancement opportunity. A shopper browsing through a discount retailers merchandise aisle filled with a wide variety of items. Dollar Tree, Inc. (NASDAQ:DLTR) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 67 hedge fund portfolios held Dollar Tree, Inc. (NASDAQ:DLTR) at the end of the first quarter, which was 64 in the previous quarter. While we acknowledge the potential of Dollar Tree, Inc. (NASDAQ:DLTR) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. In another article, we covered Dollar Tree, Inc. (NASDAQ:DLTR) and shared the list of defensive stocks billionaires are buying amid US trade tariff uncertainty. In addition, please check out our hedge fund investor letters Q2 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Ultragenyx to Host Conference Call for Second Quarter 2025 Financial Results and Corporate Update
Ultragenyx to Host Conference Call for Second Quarter 2025 Financial Results and Corporate Update

Yahoo

time10 minutes ago

  • Yahoo

Ultragenyx to Host Conference Call for Second Quarter 2025 Financial Results and Corporate Update

NOVATO, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultra-rare genetic diseases, today announced that it will host a conference call at 5:00 p.m. ET on Tuesday, August 5, 2025, to discuss its financial results and corporate update for the quarter ending June 30, 2025. The live and replayed webcast of the call will be available through the company's website at The replay of the call will be available for three months. About Ultragenyx Pharmaceutical is a biopharmaceutical company committed to bringing novel products to patients for the treatment of serious rare and ultra-rare genetic diseases. The company has built a diverse portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need and clear biology for treatment, for which there are typically no approved therapies treating the underlying disease. The company is led by a management team experienced in the development and commercialization of rare disease therapeutics. Ultragenyx's strategy is predicated upon time- and cost-efficient drug development, with the goal of delivering safe and effective therapies to patients with the utmost urgency. For more information on Ultragenyx, please visit the company's website at: Contact Ultragenyx InvestorsJoshua Higair@ MediaJess Rowlands media@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Marvell Technology stock soars 10% on Microsoft AI chip prospects
Marvell Technology stock soars 10% on Microsoft AI chip prospects

Yahoo

time10 minutes ago

  • Yahoo

Marvell Technology stock soars 10% on Microsoft AI chip prospects

-- Marvell Technology (NASDAQ:MRVL) stock surged 10% Wednesday after Fubon Research analysts highlighted the company's potential significant revenue opportunity from Microsoft's (NASDAQ:MSFT) AI chip initiatives. According to Fubon Research, Microsoft has upgraded specifications for its Maia300 chip, which Marvell is developing, from 3nm with HBM3E to a more advanced 2nm with HBM4. While this has pushed the production timeline from the first quarter of 2026 to the fourth quarter, analysts believe the project represents a substantial opportunity for Marvell. The Maia300 chip is expected to begin production with 300,000-400,000 units in the fourth quarter of 2026, ramping up to 1.2-1.5 million units in 2027. With an estimated average selling price of $8,000 per chip, Fubon projects potential revenue of $2.4 billion in 2026 and $10-12 billion in 2027 from this project alone. Analysts noted that Microsoft appears to be placing "higher expectations on Maia300 by MRVL, rather than Maia200 which is its own solution." This shift comes as Microsoft reportedly faces challenges with its internal chip design capabilities, with Fubon indicating the tech giant is likely to "rely more on MRVL for the current generations." The research also highlighted that Microsoft has increased the planned volume for its Maia200 chip from 40,000-60,000 units to 150,000-200,000 units in 2026, compensating for the delayed Maia300 rollout. Fubon's report suggests Microsoft may be more generous in pricing than Amazon (NASDAQ:AMZN) Web Services, with Maia300's $8,000 ASP substantially higher than AWS Trainium 2's $1,500, despite both projects having similar turnkey margins of 55-60%. Related articles Marvell Technology stock soars 10% on Microsoft AI chip prospects Clients buying into summer rally, bracing for later pullback, says BofA's Hartnett These Under-the-Radar Stocks Offer Better Risk-Reward Ratio Than Nvidia Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store